Lifecare ASA: Mandatory notification of trade

13 Mar 2026 16:49 CET

The Company has been informed that Teigland Eiendom AS, a company closely
associated with Trine Teigland, board member and primary insider of Lifecare
ASA, has exercised 3,072,447 warrants in Warrants Series 1 for the
subscription of 3,072,447 new shares in the Company at a price of NOK 0.3342
per share.

The Company has also been informed that Teigland Eiendom AS has sold 3,000,000
shares at a price of NOK 0.4824 per share.

Following this transaction, Teigland Eiendom AS holds 9,682,136 shares, no
warrants in Warrant Series 1 and 7,860,000 warrants in Warrant Series 2 in the
Company.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-03-13 16:49 CET.

More information:
Access the news on Oslo Bors NewsWeb site

668336_260313 PDMR Attachment Teigland Eiendom Warrants.pdf
668336_Lifecare ASA- Mandatory notification of trade.pdf
668336_260313 PDMR Attachment Teigland Eiendom Shares.pdf